1:25-cv-01332 AbbVie Inc. et al v. Deva Holding A.S.
Case Summary
AbbVie Inc. and others are plaintiffs in a case against Deva Holding A.S. The latest docket entry is an answer to a counterclaim, indicating responsive pleadings have been filed and the case is progressing through the pleadings phase. The dispute likely involves pharmaceutical or patent-related issues given the parties involved.
Stage
Active litigation
Timeline
2 events
Coverage
2 articles
Sources
1
Key Issues
- • Answer to counterclaim
- • Pharmaceutical litigation
- • Parties: AbbVie Inc. and Deva Holding A.S
Case Timeline
2 events3:25-cv-19039 ABBVIE INC. et al v. DR. REDDY'S LABORATORIES, LTD. et al
In the case AbbVie Inc. et al v. Deva Holding A.S., a related event occurred involving AbbVie Inc. and Dr. Reddy's Laboratories, Ltd., where an answer to a counterclaim was filed. This means that AbbVie responded formally to allegations made by Dr. Reddy's in a related lawsuit. Such filings are important as they clarify each party's position and help move the case forward.
1:25-cv-01332 AbbVie Inc. et al v. Deva Holding A.S.
In the case AbbVie Inc. et al v. Deva Holding A.S., new attorneys who are permitted to practice pro hac vice (PHV) have been added to the case. This means lawyers who are not licensed in the jurisdiction but have been granted special permission to participate are now officially involved. This can impact the legal strategy and representation in the case.